<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2006-03-07" modified="2020-08-12" version="149">
<accession>Q99638</accession>
<accession>B2RCZ8</accession>
<accession>Q6FI29</accession>
<accession>Q96C41</accession>
<name>RAD9A_HUMAN</name>
<protein>
<recommendedName>
<fullName>Cell cycle checkpoint control protein RAD9A</fullName>
<shortName>hRAD9</shortName>
<ecNumber>3.1.11.2</ecNumber>
</recommendedName>
<alternativeName>
<fullName>DNA repair exonuclease rad9 homolog A</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">RAD9A</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Proc. Natl. Acad. Sci. U.S.A." volume="93" first="13890" last="13895">
<title>A human homolog of the Schizosaccharomyces pombe rad9+ checkpoint control gene.</title>
<authorList>
<person name="Lieberman H.B."/>
<person name="Hopkins K.M."/>
<person name="Nass M."/>
<person name="Demetrick D."/>
<person name="Davey S."/>
</authorList>
<dbReference type="PubMed" id="8943031"/>
<dbReference type="DOI" id="10.1073/pnas.93.24.13890"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="submission" date="2004-06" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201).</title>
<authorList>
<person name="Ebert L."/>
<person name="Schick M."/>
<person name="Neubert P."/>
<person name="Schatten R."/>
<person name="Henze S."/>
<person name="Korn B."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="3">
<citation type="submission" date="2004-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS PHE-3; ALA-100; ARG-239 AND THR-307</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Trachea</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="24428" last="24437">
<title>Phosphorylation of human Rad9 is required for genotoxin-activated checkpoint signaling.</title>
<authorList>
<person name="Roos-Mattjus P."/>
<person name="Hopkins K.M."/>
<person name="Oestreich A.J."/>
<person name="Vroman B.T."/>
<person name="Johnson K.L."/>
<person name="Naylor S."/>
<person name="Lieberman H.B."/>
<person name="Karnitz L.M."/>
</authorList>
<dbReference type="PubMed" id="12709442"/>
<dbReference type="DOI" id="10.1074/jbc.m301544200"/>
</citation>
<scope>PROTEIN SEQUENCE OF 270-280; 326-329; 373-383 AND 385-390</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>PHOSPHORYLATION AT SER-272; SER-277; SER-328; SER-341; SER-375; SER-380 AND SER-387</scope>
<scope>MUTAGENESIS OF SER-272; SER-277; SER-328; SER-341; SER-375; SER-380 AND SER-387</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1999" name="Mol. Biol. Cell" volume="10" first="1985" last="1995">
<title>The human G2 checkpoint control protein hRAD9 is a nuclear phosphoprotein that forms complexes with hRAD1 and hHUS1.</title>
<authorList>
<person name="St Onge R.P."/>
<person name="Udell C.M."/>
<person name="Casselman R."/>
<person name="Davey S."/>
</authorList>
<dbReference type="PubMed" id="10359610"/>
<dbReference type="DOI" id="10.1091/mbc.10.6.1985"/>
</citation>
<scope>INTERACTION WITH HUS1 AND RAD1</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2000" name="Genomics" volume="65" first="24" last="33">
<title>Physical interaction among human checkpoint control proteins HUS1p, RAD1p, and RAD9p, and implications for the regulation of cell cycle progression.</title>
<authorList>
<person name="Hang H."/>
<person name="Lieberman H.B."/>
</authorList>
<dbReference type="PubMed" id="10777662"/>
<dbReference type="DOI" id="10.1006/geno.2000.6142"/>
</citation>
<scope>INTERACTION WITH HUS1 AND RAD1</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="7451" last="7454">
<title>Human DNA damage checkpoint protein hRAD9 is a 3' to 5' exonuclease.</title>
<authorList>
<person name="Bessho T."/>
<person name="Sancar A."/>
</authorList>
<dbReference type="PubMed" id="10713044"/>
<dbReference type="DOI" id="10.1074/jbc.275.11.7451"/>
</citation>
<scope>FUNCTION IN EXONUCLEASE ACTIVITY</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="27909" last="27916">
<title>HDAC1, a histone deacetylase, forms a complex with Hus1 and Rad9, two G2/M checkpoint Rad proteins.</title>
<authorList>
<person name="Cai R.L."/>
<person name="Yan-Neale Y."/>
<person name="Cueto M.A."/>
<person name="Xu H."/>
<person name="Cohen D."/>
</authorList>
<dbReference type="PubMed" id="10846170"/>
<dbReference type="DOI" id="10.1074/jbc.m000168200"/>
</citation>
<scope>IDENTIFICATION IN THE 9-1-1 COMPLEX ASSOCIATED WITH HDAC1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="29767" last="29771">
<title>The human checkpoint protein hRad17 interacts with the PCNA-like proteins hRad1, hHus1, and hRad9.</title>
<authorList>
<person name="Rauen M."/>
<person name="Burtelow M.A."/>
<person name="Dufault V.M."/>
<person name="Karnitz L.M."/>
</authorList>
<dbReference type="PubMed" id="10884395"/>
<dbReference type="DOI" id="10.1074/jbc.m005782200"/>
</citation>
<scope>IDENTIFICATION IN THE 9-1-1 COMPLEX ASSOCIATED WITH RAD17</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2001" name="Biochem. Biophys. Res. Commun." volume="287" first="932" last="940">
<title>The J domain of Tpr2 regulates its interaction with the proapoptotic and cell-cycle checkpoint protein, Rad9.</title>
<authorList>
<person name="Xiang S.L."/>
<person name="Kumano T."/>
<person name="Iwasaki S.I."/>
<person name="Sun X."/>
<person name="Yoshioka K."/>
<person name="Yamamoto K.C."/>
</authorList>
<dbReference type="PubMed" id="11573955"/>
<dbReference type="DOI" id="10.1006/bbrc.2001.5685"/>
</citation>
<scope>INTERACTION WITH DNAJC7</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="3292" last="3300">
<title>c-Abl tyrosine kinase regulates the human Rad9 checkpoint protein in response to DNA damage.</title>
<authorList>
<person name="Yoshida K."/>
<person name="Komatsu K."/>
<person name="Wang H.-G."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="11971963"/>
<dbReference type="DOI" id="10.1128/mcb.22.10.3292-3300.2002"/>
</citation>
<scope>INTERACTION WITH ABL1 AND BCL2L1</scope>
<scope>PHOSPHORYLATION</scope>
<scope>PHOSPHORYLATION AT TYR-28</scope>
<scope>MUTAGENESIS OF TYR-28</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2003" name="Cancer Res." volume="63" first="5291" last="5298">
<title>Expression of mammalian paralogues of HRAD9 and Mrad9 checkpoint control genes in normal and cancerous testicular tissue.</title>
<authorList>
<person name="Hopkins K.M."/>
<person name="Wang X."/>
<person name="Berlin A."/>
<person name="Hang H."/>
<person name="Thaker H.M."/>
<person name="Lieberman H.B."/>
</authorList>
<dbReference type="PubMed" id="14500360"/>
</citation>
<scope>INTERACTION WITH RAD9B</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2003" name="EMBO J." volume="22" first="1431" last="1441">
<title>Protein kinase Cdelta is responsible for constitutive and DNA damage-induced phosphorylation of Rad9.</title>
<authorList>
<person name="Yoshida K."/>
<person name="Wang H.-G."/>
<person name="Miki Y."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="12628935"/>
<dbReference type="DOI" id="10.1093/emboj/cdg134"/>
</citation>
<scope>INTERACTION WITH PRKCD</scope>
<scope>PHOSPHORYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2003" name="Proc. Natl. Acad. Sci. U.S.A." volume="100" first="1633" last="1638">
<title>Loading of the human 9-1-1 checkpoint complex onto DNA by the checkpoint clamp loader hRad17-replication factor C complex in vitro.</title>
<authorList>
<person name="Bermudez V.P."/>
<person name="Lindsey-Boltz L.A."/>
<person name="Cesare A.J."/>
<person name="Maniwa Y."/>
<person name="Griffith J.D."/>
<person name="Hurwitz J."/>
<person name="Sancar A."/>
</authorList>
<dbReference type="PubMed" id="12578958"/>
<dbReference type="DOI" id="10.1073/pnas.0437927100"/>
</citation>
<scope>ASSOCIATION OF THE 9-1-1 COMPLEX WITH THE RAD17-RFC COMPLEX</scope>
<scope>ELECTRON MICROSCOPY OF THE 9-1-1 AND RAD17-RFC COMPLEXES BOUND TO DNA</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2004" name="Nucleic Acids Res." volume="32" first="3316" last="3324">
<title>The human Rad9/Rad1/Hus1 damage sensor clamp interacts with DNA polymerase beta and increases its DNA substrate utilisation efficiency: implications for DNA repair.</title>
<authorList>
<person name="Toueille M."/>
<person name="El-Andaloussi N."/>
<person name="Frouin I."/>
<person name="Freire R."/>
<person name="Funk D."/>
<person name="Shevelev I."/>
<person name="Friedrich-Heineken E."/>
<person name="Villani G."/>
<person name="Hottiger M.O."/>
<person name="Huebscher U."/>
</authorList>
<dbReference type="PubMed" id="15314187"/>
<dbReference type="DOI" id="10.1093/nar/gkh652"/>
</citation>
<scope>IDENTIFICATION IN THE 9-1-1 COMPLEX ASSOCIATED WITH POLB</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="16762" last="16767">
<title>The human Rad9-Rad1-Hus1 checkpoint complex stimulates flap endonuclease 1.</title>
<authorList>
<person name="Wang W."/>
<person name="Brandt P."/>
<person name="Rossi M.L."/>
<person name="Lindsey-Boltz L."/>
<person name="Podust V."/>
<person name="Fanning E."/>
<person name="Sancar A."/>
<person name="Bambara R.A."/>
</authorList>
<dbReference type="PubMed" id="15556996"/>
<dbReference type="DOI" id="10.1073/pnas.0407686101"/>
</citation>
<scope>IDENTIFICATION IN THE 9-1-1 COMPLEX ASSOCIATED WITH FEN1</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2005" name="Biochem. J." volume="389" first="13" last="17">
<title>The human checkpoint sensor and alternative DNA clamp Rad9-Rad1-Hus1 modulates the activity of DNA ligase I, a component of the long-patch base excision repair machinery.</title>
<authorList>
<person name="Smirnova E."/>
<person name="Toueille M."/>
<person name="Markkanen E."/>
<person name="Huebscher U."/>
</authorList>
<dbReference type="PubMed" id="15871698"/>
<dbReference type="DOI" id="10.1042/bj20050211"/>
</citation>
<scope>IDENTIFICATION IN THE 9-1-1 COMPLEX ASSOCIATED WITH LIG1</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2005" name="J. Mol. Biol." volume="353" first="980" last="989">
<title>The two DNA clamps Rad9/Rad1/Hus1 complex and proliferating cell nuclear antigen differentially regulate flap endonuclease 1 activity.</title>
<authorList>
<person name="Friedrich-Heineken E."/>
<person name="Toueille M."/>
<person name="Taennler B."/>
<person name="Buerki C."/>
<person name="Ferrari E."/>
<person name="Hottiger M.O."/>
<person name="Huebscher U."/>
</authorList>
<dbReference type="PubMed" id="16216273"/>
<dbReference type="DOI" id="10.1016/j.jmb.2005.09.018"/>
</citation>
<scope>IDENTIFICATION IN THE 9-1-1 COMPLEX ASSOCIATED WITH FEN1</scope>
<scope>INTERACTION WITH FEN1</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2005" name="Oncogene" volume="24" first="4728" last="4735">
<title>Interaction and colocalization of Rad9/Rad1/Hus1 checkpoint complex with replication protein A in human cells.</title>
<authorList>
<person name="Wu X."/>
<person name="Shell S.M."/>
<person name="Zou Y."/>
</authorList>
<dbReference type="PubMed" id="15897895"/>
<dbReference type="DOI" id="10.1038/sj.onc.1208674"/>
</citation>
<scope>IDENTIFICATION IN THE 9-1-1 COMPLEX ASSOCIATED WITH RPA1 AND RPA2</scope>
<scope>INTERACTION WITH RPA1 AND RPA2</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-375; SER-380 AND SER-387</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-277 AND SER-387</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-277; SER-375 AND SER-387</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-277; SER-375 AND SER-387</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="28">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-387</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2011" name="Science" volume="332" first="1313" last="1317">
<title>A DNA damage response screen identifies RHINO, a 9-1-1 and TopBP1 interacting protein required for ATR signaling.</title>
<authorList>
<person name="Cotta-Ramusino C."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K."/>
<person name="Sowa M.E."/>
<person name="Harper J.W."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="21659603"/>
<dbReference type="DOI" id="10.1126/science.1203430"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RHNO1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-328 AND SER-387</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="32">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<comment type="function">
<text evidence="13 27">Component of the 9-1-1 cell-cycle checkpoint response complex that plays a major role in DNA repair. The 9-1-1 complex is recruited to DNA lesion upon damage by the RAD17-replication factor C (RFC) clamp loader complex. Acts then as a sliding clamp platform on DNA for several proteins involved in long-patch base excision repair (LP-BER). The 9-1-1 complex stimulates DNA polymerase beta (POLB) activity by increasing its affinity for the 3'-OH end of the primer-template and stabilizes POLB to those sites where LP-BER proceeds; endonuclease FEN1 cleavage activity on substrates with double, nick, or gap flaps of distinct sequences and lengths; and DNA ligase I (LIG1) on long-patch base excision repair substrates. The 9-1-1 complex is necessary for the recruitment of RHNO1 to sites of double-stranded breaks (DSB) occurring during the S phase. RAD9A possesses 3'-&gt;5' double stranded DNA exonuclease activity. Its phosphorylation by PRKCD may be required for the formation of the 9-1-1 complex.</text>
</comment>
<comment type="catalytic activity">
<reaction>
<text>Exonucleolytic cleavage in the 3'- to 5'-direction to yield nucleoside 5'-phosphates.</text>
<dbReference type="EC" id="3.1.11.2"/>
</reaction>
</comment>
<comment type="subunit">
<text evidence="12 14 15 16 17 18 19 21 22 23 24 25 26 27">Component of the toroidal 9-1-1 (RAD9-RAD1-HUS1) complex, composed of RAD9A, RAD1 and HUS1. The 9-1-1 complex associates with LIG1, POLB, FEN1, RAD17, HDAC1, RPA1 and RPA2. The 9-1-1 complex associates with the RAD17-RFC complex. RAD9A interacts with BCL2L1, FEN1, PRKCD, RAD9B, HUS1, RAD1, ABL1, RPA1, ATAD5 and RPA2. Interacts with DNAJC7 and RHNO1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2606224">
<id>Q99638</id>
</interactant>
<interactant intactId="EBI-1056174">
<id>O60921</id>
<label>HUS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2606224">
<id>Q99638</id>
</interactant>
<interactant intactId="EBI-721835">
<id>O60671</id>
<label>RAD1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="19">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="PTM">
<text evidence="18 19 20">Constitutively phosphorylated on serine and threonine amino acids in absence of DNA damage. Hyperphosphorylated by PRKCD and ABL1 upon DNA damage. Its phosphorylation by PRKCD may be required for the formation of the 9-1-1 complex.</text>
</comment>
<comment type="similarity">
<text evidence="29">Belongs to the rad9 family.</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/rad9a/"/>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/RAD9AID42031ch11q13.html"/>
</comment>
<dbReference type="EC" id="3.1.11.2"/>
<dbReference type="EMBL" id="U53174">
<property type="protein sequence ID" value="AAB39928.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR536508">
<property type="protein sequence ID" value="CAG38746.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY766122">
<property type="protein sequence ID" value="AAU89725.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK315348">
<property type="protein sequence ID" value="BAG37745.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471076">
<property type="protein sequence ID" value="EAW74605.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC014848">
<property type="protein sequence ID" value="AAH14848.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS8159.1"/>
<dbReference type="RefSeq" id="NP_001230153.1">
<property type="nucleotide sequence ID" value="NM_001243224.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004575.1">
<property type="nucleotide sequence ID" value="NM_004584.2"/>
</dbReference>
<dbReference type="PDB" id="3A1J">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1-266"/>
</dbReference>
<dbReference type="PDB" id="3G65">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=1-270"/>
</dbReference>
<dbReference type="PDB" id="3GGR">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A=1-270"/>
</dbReference>
<dbReference type="PDB" id="6HM5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.33"/>
<property type="chains" value="B=380-390"/>
</dbReference>
<dbReference type="PDB" id="6J8Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=1-270"/>
</dbReference>
<dbReference type="PDBsum" id="3A1J"/>
<dbReference type="PDBsum" id="3G65"/>
<dbReference type="PDBsum" id="3GGR"/>
<dbReference type="PDBsum" id="6HM5"/>
<dbReference type="PDBsum" id="6J8Y"/>
<dbReference type="SMR" id="Q99638"/>
<dbReference type="BioGRID" id="111820">
<property type="interactions" value="54"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1829">
<property type="entry name" value="Checkpoint clamp complex"/>
</dbReference>
<dbReference type="CORUM" id="Q99638"/>
<dbReference type="DIP" id="DIP-24255N"/>
<dbReference type="DIP" id="DIP-40930N"/>
<dbReference type="IntAct" id="Q99638">
<property type="interactions" value="10"/>
</dbReference>
<dbReference type="MINT" id="Q99638"/>
<dbReference type="STRING" id="9606.ENSP00000311360"/>
<dbReference type="iPTMnet" id="Q99638"/>
<dbReference type="PhosphoSitePlus" id="Q99638"/>
<dbReference type="BioMuta" id="RAD9A"/>
<dbReference type="DMDM" id="74717382"/>
<dbReference type="EPD" id="Q99638"/>
<dbReference type="jPOST" id="Q99638"/>
<dbReference type="MassIVE" id="Q99638"/>
<dbReference type="MaxQB" id="Q99638"/>
<dbReference type="PaxDb" id="Q99638"/>
<dbReference type="PeptideAtlas" id="Q99638"/>
<dbReference type="PRIDE" id="Q99638"/>
<dbReference type="ProteomicsDB" id="78371"/>
<dbReference type="Antibodypedia" id="1880">
<property type="antibodies" value="1112 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000307980">
<property type="protein sequence ID" value="ENSP00000311360"/>
<property type="gene ID" value="ENSG00000172613"/>
</dbReference>
<dbReference type="GeneID" id="5883"/>
<dbReference type="KEGG" id="hsa:5883"/>
<dbReference type="UCSC" id="uc001okr.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5883"/>
<dbReference type="DisGeNET" id="5883"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000172613.7"/>
<dbReference type="GeneCards" id="RAD9A"/>
<dbReference type="HGNC" id="HGNC:9827">
<property type="gene designation" value="RAD9A"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000172613">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="603761">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q99638"/>
<dbReference type="OpenTargets" id="ENSG00000172613"/>
<dbReference type="PharmGKB" id="PA294"/>
<dbReference type="eggNOG" id="KOG2810">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000005767"/>
<dbReference type="InParanoid" id="Q99638"/>
<dbReference type="KO" id="K10994"/>
<dbReference type="OMA" id="DERMWVR"/>
<dbReference type="OrthoDB" id="1176140at2759"/>
<dbReference type="PhylomeDB" id="Q99638"/>
<dbReference type="TreeFam" id="TF101212"/>
<dbReference type="PathwayCommons" id="Q99638"/>
<dbReference type="Reactome" id="R-HSA-176187">
<property type="pathway name" value="Activation of ATR in response to replication stress"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5685938">
<property type="pathway name" value="HDR through Single Strand Annealing (SSA)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693607">
<property type="pathway name" value="Processing of DNA double-strand break ends"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693616">
<property type="pathway name" value="Presynaptic phase of homologous DNA pairing and strand exchange"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804756">
<property type="pathway name" value="Regulation of TP53 Activity through Phosphorylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69473">
<property type="pathway name" value="G2/M DNA damage checkpoint"/>
</dbReference>
<dbReference type="SignaLink" id="Q99638"/>
<dbReference type="SIGNOR" id="Q99638"/>
<dbReference type="BioGRID-ORCS" id="5883">
<property type="hits" value="521 hits in 876 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="RAD9A">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q99638"/>
<dbReference type="GeneWiki" id="RAD9A"/>
<dbReference type="GenomeRNAi" id="5883"/>
<dbReference type="Pharos" id="Q99638">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q99638"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 11"/>
</dbReference>
<dbReference type="RNAct" id="Q99638">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000172613">
<property type="expression patterns" value="Expressed in right uterine tube and 183 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q99638">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q99638">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030896">
<property type="term" value="C:checkpoint clamp complex"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008408">
<property type="term" value="F:3'-5' exonuclease activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008853">
<property type="term" value="F:exodeoxyribonuclease III activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0042826">
<property type="term" value="F:histone deacetylase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0017124">
<property type="term" value="F:SH3 domain binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071479">
<property type="term" value="P:cellular response to ionizing radiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000077">
<property type="term" value="P:DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006281">
<property type="term" value="P:DNA repair"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006260">
<property type="term" value="P:DNA replication"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000076">
<property type="term" value="P:DNA replication checkpoint"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0031573">
<property type="term" value="P:intra-S DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:1902231">
<property type="term" value="P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1901796">
<property type="term" value="P:regulation of signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="InterPro" id="IPR026584">
<property type="entry name" value="Rad9"/>
</dbReference>
<dbReference type="InterPro" id="IPR007268">
<property type="entry name" value="Rad9/Ddc1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR15237">
<property type="entry name" value="PTHR15237"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF04139">
<property type="entry name" value="Rad9"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF009303">
<property type="entry name" value="Cell_cycle_RAD9"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0269">Exonuclease</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0540">Nuclease</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<feature type="chain" description="Cell cycle checkpoint control protein RAD9A" id="PRO_0000225000">
<location>
<begin position="1"/>
<end position="391"/>
</location>
</feature>
<feature type="region of interest" description="Possesses 3'-5' exonuclease activity">
<location>
<begin position="51"/>
<end position="91"/>
</location>
</feature>
<feature type="region of interest" description="Sufficient for interaction with ABL1" evidence="18">
<location>
<begin position="266"/>
<end position="391"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="18">
<location>
<position position="28"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="20">
<location>
<position position="272"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 8 9 20">
<location>
<position position="277"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 20">
<location>
<position position="328"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="20">
<location>
<position position="341"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 8 9 20">
<location>
<position position="375"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 20">
<location>
<position position="380"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 7 8 9 10 11 20">
<location>
<position position="387"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11575913." id="VAR_025410" evidence="28">
<original>C</original>
<variation>F</variation>
<location>
<position position="3"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2422490." id="VAR_051724">
<original>L</original>
<variation>Q</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2066492." id="VAR_025411" evidence="28">
<original>S</original>
<variation>A</variation>
<location>
<position position="100"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17880039." id="VAR_025412" evidence="28">
<original>H</original>
<variation>R</variation>
<location>
<position position="239"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17882466." id="VAR_025413" evidence="28">
<original>M</original>
<variation>T</variation>
<location>
<position position="307"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation by ABL1." evidence="18">
<original>Y</original>
<variation>F</variation>
<location>
<position position="28"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of phosphorylation and no loss of interaction with the 9-1-1 complex; when associated with A-277; A-328; A-341; A-375; A-380 and A-387." evidence="20">
<original>S</original>
<variation>A</variation>
<location>
<position position="272"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of phosphorylation and no loss of interaction with the 9-1-1 complex; when associated with A-272; A-328; A-341; A-375; A-380 and A-387." evidence="20">
<original>S</original>
<variation>A</variation>
<location>
<position position="277"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of phosphorylation and no loss of interaction with the 9-1-1 complex; when associated with A-272; A-277; A-341; A-375; A-380 and A-387." evidence="20">
<original>S</original>
<variation>A</variation>
<location>
<position position="328"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of phosphorylation and no loss of interaction with the 9-1-1 complex; when associated with A-272; A-277; A-328; A-375; A-380 and A-387." evidence="20">
<original>S</original>
<variation>A</variation>
<location>
<position position="341"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of phosphorylation and no loss of interaction with the 9-1-1 complex; when associated with A-272; A-277; A-328; A-341; A-380 and A-387." evidence="20">
<original>S</original>
<variation>A</variation>
<location>
<position position="375"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of phosphorylation and no loss of interaction with the 9-1-1 complex; when associated with A-272; A-277; A-328; A-341; A-375 and A-387." evidence="20">
<original>S</original>
<variation>A</variation>
<location>
<position position="380"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of phosphorylation and no loss of interaction with the 9-1-1 complex; when associated with A-272; A-277; A-328; A-341; A-375 and A-380." evidence="20">
<original>S</original>
<variation>A</variation>
<location>
<position position="387"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAG38746." ref="2" evidence="29">
<original>V</original>
<variation>A</variation>
<location>
<position position="12"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAH14848." ref="6" evidence="29">
<original>E</original>
<variation>A</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="2"/>
<end position="6"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="9"/>
<end position="20"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="21"/>
<end position="23"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="25"/>
<end position="32"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="35"/>
<end position="41"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="43"/>
<end position="45"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="47"/>
<end position="53"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="55"/>
<end position="57"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="58"/>
<end position="62"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="66"/>
<end position="68"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="73"/>
<end position="76"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="77"/>
<end position="83"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="87"/>
<end position="92"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="94"/>
<end position="100"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="103"/>
<end position="106"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="107"/>
<end position="114"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="115"/>
<end position="117"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="119"/>
<end position="125"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="138"/>
<end position="140"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="142"/>
<end position="148"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="149"/>
<end position="156"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="165"/>
<end position="171"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="172"/>
<end position="174"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="175"/>
<end position="180"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="187"/>
<end position="189"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="194"/>
<end position="199"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="201"/>
<end position="203"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="205"/>
<end position="208"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="214"/>
<end position="218"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="219"/>
<end position="230"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="231"/>
<end position="233"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="235"/>
<end position="240"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="241"/>
<end position="245"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="247"/>
<end position="252"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="254"/>
<end position="262"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="267"/>
<end position="269"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="382"/>
<end position="384"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3A1J"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3G65"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3GGR"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6HM5"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6J8Y"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10359610"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10713044"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10777662"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10846170"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10884395"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11573955"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11971963"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12628935"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12709442"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14500360"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15314187"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15556996"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15871698"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15897895"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16216273"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21659603"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="29" type="ECO:0000305"/>
<sequence length="391" mass="42547" checksum="4D4D6D4C6E1057D3" modified="1997-05-01" version="1">MKCLVTGGNVKVLGKAVHSLSRIGDELYLEPLEDGLSLRTVNSSRSAYACFLFAPLFFQQYQAATPGQDLLRCKILMKSFLSVFRSLAMLEKTVEKCCISLNGRSSRLVVQLHCKFGVRKTHNLSFQDCESLQAVFDPASCPHMLRAPARVLGEAVLPFSPALAEVTLGIGRGRRVILRSYHEEEADSTAKAMVTEMCLGEEDFQQLQAQEGVAITFCLKEFRGLLSFAESANLNLSIHFDAPGRPAIFTIKDSLLDGHFVLATLSDTDSHSQDLGSPERHQPVPQLQAHSTPHPDDFANDDIDSYMIAMETTIGNEGSRVLPSISLSPGPQPPKSPGPHSEEEDEAEPSTVPGTPPPKKFRSLFFGSILAPVRSPQGPSPVLAEDSEGEG</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

